+499.5%
MRNA vs AVTR
+16.8%
+482.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AVTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.4% | -0.8% | -1.4% |
| 7D | +5.5% | +2.7% | +2.8% | +3.5% |
| 30D | +158.7% | +12.1% | +146.7% | +144.3% |
| 3M | +182.1% | +57.2% | +124.9% | +134.8% |
| 6M | +151.8% | +73.1% | +78.8% | +102.5% |
| YTD | +393.6% | +30.6% | +362.9% | +334.4% |
| 1Y | +499.5% | +13.5% | +486.0% | +412.7% |
| All | +499.5% | +16.8% | +482.7% | +412.7% |
Cumulative growth
Daily Returns
Daily percentage return beside AVTR.
Daily Out/Under-Performance
Portfolio return minus AVTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AVTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling